31 results
DEF 14A
BEAM
Beam Therapeutics Inc
23 Apr 21
Definitive proxy
4:05pm
of Mr. Cooper and Ms. Walsh is an “audit committee financial expert,” as defined under Item 407 of Regulation S-K.
During the fiscal year ended December
10-K
4o2kcz8
30 Mar 20
Annual report
5:26pm
8-K
EX-3.2
1lm3ozk
11 Feb 20
Amendments to Articles of Incorporation or Bylaws
4:05pm
424B4
idcif
7 Feb 20
Prospectus supplement with pricing info
12:00am
S-1/A
st24xp3cfx1p1lecgnl
17 Jan 20
IPO registration (amended)
4:09pm
S-1
EX-10.6
jxes aprl
27 Sep 19
IPO registration
4:34pm
S-1
EX-10.7
ux063
27 Sep 19
IPO registration
4:34pm
S-1
EX-10.9
aj39z19lkk7jy6f0xnpl
27 Sep 19
IPO registration
4:34pm
S-1
EX-10.10
4v6l04s8lj2qo
27 Sep 19
IPO registration
4:34pm
S-1
EX-10.12
4erx9o8149if5ta
27 Sep 19
IPO registration
4:34pm
S-1
EX-10.11
58sll0zblssdi
27 Sep 19
IPO registration
4:34pm
S-1
bgnp45vdaj3ci
27 Sep 19
IPO registration
4:34pm
S-1
EX-10.5
amqo4737fajb2
27 Sep 19
IPO registration
4:34pm